Spectrophotometry in infrared region: A new, low cost and green way to analyze tablets of rifaximin

dc.contributor.authorKogawa, Ana Carolina [UNESP]
dc.contributor.authorSalgado, Hérida Regina Nunes [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2018-12-11T17:36:05Z
dc.date.available2018-12-11T17:36:05Z
dc.date.issued2018-03-01
dc.description.abstractBackground: Rifaximin is an oral antimicrobial, which, until now, does not have standardized analytical methods in most official compendia. The literature shows few methods for the detection of drug, but has no analytical method for the determination of rifaximin in the pharmaceutical product. The lack of environmentally friendly methods with the use and minimal generation of toxic waste is also a gap. Methods: This work proposed the development and validation of an infrared spectrophotometry method for the determination of rifaximin in tablets. Results: The method was linear over the concentration range of 1.0-3.5 mg with correlation coefficient 0.9997 and the limits of detection and quantification of 0.20 and 0.61 mg, respectively. Conclusion: The validated method was adequate, reliable, fast, economical and eco-friendly for the routine quality control of rifaximin in tablets. In the current fight against climate change, we can and must do our role, even if the role part is to develop and validate environmentally friendly method for routine use in the quality control of drugs and medicines in laboratories and pharmaceutical industries.en
dc.description.affiliationDepartment of Pharmaceutics School of Pharmaceutical Sciences of Araraquara Univ Estadual Paulista - UNESP
dc.description.affiliationUnespDepartment of Pharmaceutics School of Pharmaceutical Sciences of Araraquara Univ Estadual Paulista - UNESP
dc.description.sponsorshipCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
dc.description.sponsorshipConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.format.extent108-115
dc.identifierhttp://dx.doi.org/10.2174/1573412913666161213103657
dc.identifier.citationCurrent Pharmaceutical Analysis, v. 14, n. 2, p. 108-115, 2018.
dc.identifier.doi10.2174/1573412913666161213103657
dc.identifier.issn1875-676X
dc.identifier.issn1573-4129
dc.identifier.scopus2-s2.0-85042788999
dc.identifier.urihttp://hdl.handle.net/11449/179627
dc.language.isoeng
dc.relation.ispartofCurrent Pharmaceutical Analysis
dc.relation.ispartofsjr0,224
dc.rights.accessRightsAcesso restrito
dc.sourceScopus
dc.subjectAntimicrobial
dc.subjectEnvironmentally friendly
dc.subjectInfrared
dc.subjectMethod validation
dc.subjectRifaximin
dc.subjectTablets
dc.titleSpectrophotometry in infrared region: A new, low cost and green way to analyze tablets of rifaximinen
dc.typeArtigo
unesp.departmentFármacos e Medicamentos - FCFpt

Arquivos